feed,title,long_url,short_url
Benzinga,Tencent To Acquire Remaining Stake In Sumo Group At 43% Premium: Bloomberg,https://benzinga.com/m-a/21/07/22035110/tencent-to-acquire-remaining-stake-in-sumo-group-at-43-premium-bloomberg,https://j.mp/3zd4LeK
Benzinga,FibroGen Out-Licenses Recombinant Human Collagen-Based Biosynthetic Cornea,https://benzinga.com/general/biotech/21/07/22037851/fibrogen-out-licenses-recombinant-human-collagen-based-biosynthetic-cornea,https://j.mp/2UXeE10
